Evaluation of Topical Sclerosant Agents for Minimization of Postmastectomy Seroma: A Placebo-Controlled, Double-Blind, Randomized Trial
-
Published:2023-04-01
Issue:2
Volume:19
Page:134-139
-
ISSN:2587-0831
-
Container-title:European Journal of Breast Health
-
language:
-
Short-container-title:EJBH
Author:
Khater AshrafORCID,
Hassan AhmedORCID,
Farouk OmarORCID,
Sinbel AhmedORCID,
Saleh SalehORCID,
Abdelaziz MahmoudORCID,
Eldamshety OsamaORCID
Publisher
Galenos Yayinevi
Subject
Ocean Engineering
Reference21 articles.
1. 1. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol 2006; 36: 197-206. (PMID: 16684859) [Crossref]
2. 2. Boostrom SY, Throckmorton AD, Boughey JC, Holifield AC, Zakaria S, Hoskin TL, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 2009; 208: 148-150. (PMID: 19228516) [Crossref]
3. 3. Soon PS, Clark J, Magarey CJ. Seroma formation after axillary lymphadenectomy with and without the use of drains. Breast 2005; 14: 103-107. (PMID: 15767179) [Crossref]
4. 4. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al. Pathophysiology of seroma in breast cancer. Breast Cancer 2005; 12: 288-293. (PMID: 16286909) [Crossref]
5. 5. Saydam S, Harmancioglu O. Seroma prevention. Eur Surg Res 2001; 33: 8-245. [Crossref]